We are live on ! Find out more
FMI

F/M Investments Portfolio holdings

AUM $1.97B
1-Year Est. Return 30.33%
This Fund
S&P 500
This Quarter Est. Return
-2.84%
1 Year Est. Return
+30.33%
3 Year Est. Return
+101.46%
5 Year Est. Return
+144.03%
10 Year Est. Return
–
AUM
$2.51B
AUM Growth
-$201M
Cap. Flow
-$78.6M
Cap. Flow %
-3.13%
Top 10 Hldgs %
32.12%
Holding
422
New
23
Increased
129
Reduced
193
Closed
31

Top Buys

Rank Stock Value
1
IDXX icon
Idexx Laboratories
IDXX
+$11.8M
2
C icon
Citigroup
C
+$6.42M
3
BLK icon
Blackrock
BLK
+$5.5M
4
HUBS icon
HubSpot
HUBS
+$4.88M
5
LRCX icon
Lam Research
LRCX
+$4.71M

Top Sells

Rank Stock Value
1
UNH icon
UnitedHealth
UNH
+$18.7M
2
ZTWO icon
F/M 2-Year Investment Grade Corporate Bond ETF
ZTWO
+$18.5M
3
AAPL icon
Apple
AAPL
+$10.2M
4
TFC icon
Truist Financial
TFC
+$9.55M
5
TBIL
F/m US Treasury 3 Month Bill Fund
TBIL
+$6.55M

Sector Composition

Rank Sector Weight
1 Technology 21.71%
2 Healthcare 11.09%
3 Financials 10.98%
4 Consumer Discretionary 8.01%
5 Industrials 7.96%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MYRG icon
401
MYR Group
MYRG
$5.25B
– –
-14,667
Closed -$2.18M
NSSC icon
402
Napco Security Technologies
NSSC
$1.48B
– –
-66,069
Closed -$2.35M
OC icon
403
Owens Corning
OC
$12.4B
– –
-1,684
Closed -$287K
P
404
Everpure Inc
P
$29.9B
– –
-4,511
Closed -$277K
QTRX icon
405
Quanterix
QTRX
$190M
– –
-59,922
Closed -$637K
RXST icon
406
RxSight
RXST
$260M
– –
-5,901
Closed -$203K
SM icon
407
SM Energy
SM
$6.87B
– –
-55,635
Closed -$2.16M
TKR icon
408
Timken Company
TKR
$9.03B
– –
-17,961
Closed -$1.28M
TTD icon
409
Trade Desk
TTD
$6.49B
– –
-1,761
Closed -$207K
VBK icon
410
Vanguard Morningstar Small-Cap Growth ETF
VBK
$24.5B
– –
-740
Closed -$207K
VERX icon
411
Vertex
VERX
$1.94B
– –
-3,792
Closed -$202K
VKTX icon
412
Viking Therapeutics
VKTX
$4B
– –
-37,575
Closed -$1.51M
VOYA icon
413
Voya Financial
VOYA
$9.19B
– –
-4,784
Closed -$329K
VTV icon
414
Vanguard Morningstar Value ETF
VTV
$191B
– –
-1,660
Closed -$281K
WBA
415
DELISTED
Walgreens Boots Alliance
WBA
– –
-14,503
Closed -$135K
WGS icon
416
GeneDx Holdings
WGS
$2.3B
– –
-7,469
Closed -$574K
Z icon
417
Zillow
Z
$7.56B
– –
-20,700
Closed -$1.53M
ZBRA icon
418
Zebra Technologies
ZBRA
$17.8B
– –
-4,144
Closed -$1.6M
ZTS icon
419
Zoetis
ZTS
$30B
– –
-1,763
Closed -$287K
RDDT icon
420
Reddit
RDDT
$31.1B
– –
-14,553
Closed -$2.38M
ITCI
421
DELISTED
Intra-Cellular Therapies Inc.
ITCI
– –
-36,920
Closed -$3.08M
13 14 15 16
17

Similar funds

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
HA
Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return
NIM
Needham Investment Management New York $1.96B AUM 101.23% 1-Year Est. Return
RMCM
Reynders McVeigh Capital Management Boston, Massachusetts $1.98B AUM 23.37% 1-Year Est. Return
FC
Finepoint Capital Boston, Massachusetts $1.95B AUM 45.61% 1-Year Est. Return
SC
Syon Capital San Francisco, California $1.99B AUM 22.67% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
BC
Blackhill Capital Morristown, New Jersey $1.94B AUM 18.09% 1-Year Est. Return

F/M Investments's Q1 2025 Portfolio in Review

As of Q1 2025, F/M Investments held 422 positions worth $2.51B, down 7.4% from $2.71B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

F/M Investments withdrew a net $78.6M in Q1 2025, closing 31 positions and reducing 193 holdings. Its most notable exit was Intra-Cellular Therapies Inc., an estimated $3.08M position sold in full.

By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 24% a quarter earlier, followed by Healthcare and Financials.

Against the trend, F/M Investments opened a new position in Idexx Laboratories worth $11.4M.

  • F/M Investments's largest Q1 2025 buy was Idexx Laboratories: 27,178 shares worth $11.4M.
  • F/M Investments added most to Palantir in Q1 2025, an estimated $3.23M increase.
  • F/M Investments's biggest Q1 2025 reduction was UnitedHealth, cutting an estimated $18.7M.
  • F/M Investments fully exited Intra-Cellular Therapies Inc. in Q1 2025, selling an estimated $3.08M.
  • F/M Investments's ten largest holdings make up 32% of its $2.51B portfolio in Q1 2025.
  • F/M Investments opened 23 new positions and closed 31 in Q1 2025.
  • F/M Investments's portfolio value fell 7.4% quarter-over-quarter to $2.51B.

Based on F/M Investments's 13F filing for Q1 2025, filed 14 May 2025.